CoChat

Genetic and epigenetic heterogeneity in acute myeloid leukemia

Open access
Li, Sheng, Mason, Christopher E, Melnick, Ari · 2016 · Current Opinion in Genetics & Development
Cited by 193

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Genetic and epigenetic heterogeneity is emerging as a fundamental property of human cancers. Reflecting the genesis of tumors as an evolutionary process driven by clonal selection. The complexity of clonal architecture has been known for many years in the setting of acute myeloid leukemia (AML), based on karyotyping studies. However the true complexity of AMLs is only now being understood thanks to in depth genome sequencing studies in humans, which reveal that heterogeneity is a multilayered and involves not only the genome but also the epigenome. Here, we review recent advances in genetic and epigenetic heterogeneity and clonal dynamics in AML and their relevance to biology, clinical outcomes and therapeutic implications. Special attention is focused on somatic mutations affecting regulators of cytosine methylation, since these tend to occur early in disease evolution, reprogram the epigenome of hematopoietic stem cells, and are linked to unfavorable outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gde.2016.03.011

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 25

  1. Gilliland, 2002, The roles of FLT3 in hematopoiesis and leukemia, Blood, 100, 1532, 10.1182/blood-2002-02-0492 · DOI · Paper page
  2. Paguirigan, 2015, Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia, Sci Transl Med, 7, 281re282, 10.1126/scitranslmed.aaa0763 · DOI · Paper page
  3. Li, 2014, Dynamic evolution of clonal epialleles revealed by methclone, Genome Biol, 15, 472, 10.1186/s13059-014-0472-5 · doi:10.1186/s13059-014-0472-5
  4. Klco, 2014, Functional heterogeneity of genetically defined subclones in acute myeloid leukemia, Cancer Cell, 25, 379, 10.1016/j.ccr.2014.01.031 · DOI · Paper page
  5. Kronke, 2013, Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia, Blood, 122, 100, 10.1182/blood-2013-01-479188 · DOI · Paper page
  6. Figueroa, 2010, DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, 17, 13, 10.1016/j.ccr.2009.11.020 · DOI · Paper page
  7. Scourzic, 2015, TET proteins and the control of cytosine demethylation in cancer, Genome Med, 7, 9, 10.1186/s13073-015-0134-6 · DOI · Paper page
  8. McKenney, 2013, Isocitrate dehydrogenase mutations in leukemia, J Clin Invest, 123, 3672, 10.1172/JCI67266 · DOI
  9. Rampal, 2014, DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia, Cell Rep, 9, 1841, 10.1016/j.celrep.2014.11.004 · DOI · Paper page
  10. Wang, 2015, WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation, Mol Cell, 57, 662, 10.1016/j.molcel.2014.12.023 · DOI · Paper page
  11. Patel, 2012, Prognostic relevance of integrated genetic profiling in acute myeloid leukemia, N Engl J Med, 366, 1079, 10.1056/NEJMoa1112304 · DOI · Paper page
  12. Ribeiro, 2012, Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia, Blood, 119, 5824, 10.1182/blood-2011-07-367961 · DOI · Paper page
  13. Holz-Schietinger, 2012, Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation, J Biol Chem, 287, 30941, 10.1074/jbc.M112.366625 · DOI · Paper page
  14. Challen, 2012, Dnmt3a is essential for hematopoietic stem cell differentiation, Nat Genet, 44, 23, 10.1038/ng.1009 · DOI · Paper page
  15. Ferreira, 2015, DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia, Oncogene
  16. Mayle, 2015, Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation, Blood, 125, 629, 10.1182/blood-2014-08-594648 · DOI · Paper page
  17. Guryanova, 2015, Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells, Leukemia
  18. Shaknovich, 2014, Epigenetic diversity in hematopoietic neoplasms, Biochim Biophys Acta, 1846, 477
  19. Hansen, 2011, Increased methylation variation in epigenetic domains across cancer types, Nat Genet, 43, 768, 10.1038/ng.865 · DOI · Paper page
  20. Brocks, 2014, Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer, Cell Rep, 8, 798, 10.1016/j.celrep.2014.06.053 · DOI · Paper page
  21. Landau, 2014, Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia, Cancer Cell, 26, 813, 10.1016/j.ccell.2014.10.012 · DOI · Paper page
  22. Pan, 2015, Epigenomic evolution in diffuse large B-cell lymphomas, Nat Commun, 6, 6921, 10.1038/ncomms7921 · DOI · Paper page
  23. De, 2013, Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity, PLoS Genet, 9, e1003137, 10.1371/journal.pgen.1003137 · DOI · Paper page
  24. Alizadeh, 2015, Toward understanding and exploiting tumor heterogeneity, Nat Med, 21, 846, 10.1038/nm.3915 · DOI · Paper page
  25. Kernytsky, 2015, IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition, Blood, 125, 296, 10.1182/blood-2013-10-533604 · DOI · Paper page

Cited by

See all 193

Metadata

Authors
Li, S., Mason, C. E., & Melnick, A.
Venue
Current Opinion in Genetics & Development
Publisher
Elsevier BV
Published
2016-02
Volume
36
Pages
100-106
ISSN
0959-437X (ISSN-L)
OpenAlex
W2362534374
Cited by
193
References
15
FWCI
2.10
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic and epigenetic heterogeneity in acute myeloid leukemia. https://app.cochat.ai/papers/10.1016/j.gde.2016.03.011
The paper
Li, S., Mason, C. E., & Melnick, A. (2016). Genetic and epigenetic heterogeneity in acute myeloid leukemia. Current Opinion in Genetics & Development. https://doi.org/10.1016/j.gde.2016.03.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.